Skip to main content
. 2019 Apr 5;13:1087–1098. doi: 10.2147/DDDT.S198003

Table 1.

EE and DL of NLCs (mean ± SD, n=3)

NLCs DOX EE (%) ELE EE (%) DOX DL (%) ELE DL (%)
DOX/ELE Hyd NLCs 89.3±3.9 87.7±4.2 12.1±0.8 5.7±0.7
DOX/ELE NLCs 91.8±4.6 86.9±3.8 10.8±0.9 4.9±0.6
DOX Hyd NLCs 90.5±3.7 9.6±1.1
ELE Hyd NLCs 88.6±4.9 5.2±0.8

Abbreviations: DL, drug loading; EE, entrapment efficiency; DOX/ELE Hyd NLCs, doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers.